A

Acrux
ACR

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
A$7.34M
EV
A$6.13M
Shares Outstanding
407.76M
Beta
0.89

Wall Street View

Analyst Rating
NO_OPINION
Analyst Target Price
A$0.09
P/E 2025E
-
P/Revenue 2025E
1.06x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Acrux Limited

gainify

A

Acrux Limited

ACR

Acrux Limited, together with its subsidiaries, engages in the development and commercialization of generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally. The company provides estradiol transdermal sprays for...

Sector

Healthcare

Industry

Biotechnology

CEO

Kotsanis, Michael

Employees

43

IPO Date

2004-09-29

Headquarters

103-113, Stanley Street, West Melbourne, Victoria, 3003, Australia

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.